174 related articles for article (PubMed ID: 38433536)
1. [Growth hormone - 30 years of clinical practice: past, present, future].
Dedov II; Bezlepkina OB; Pankratova MS; Nagaeva EV; Raykina EN; Peterkova VA
Probl Endokrinol (Mosk); 2024 Feb; 70(1):4-12. PubMed ID: 38433536
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
[TBL] [Abstract][Full Text] [Related]
3. Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.
Al-Abdulrazzaq D; Al-Taiar A; Hassan K; Al-Basari I
BMC Endocr Disord; 2015 Dec; 15():76. PubMed ID: 26630987
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.
Romer T; Peter F; Saenger P; Starzyk J; Koehler B; Korman E; Walczak M; Wasik R; Ginalska-Malinowska M; Solyom E; Berghout A
J Endocrinol Invest; 2007; 30(7):578-89. PubMed ID: 17848841
[TBL] [Abstract][Full Text] [Related]
5. [Influence of surgery and radiotherapy on growth and pubertal development in children treated for brain tumour].
Birkholz D; Korpal-Szczyrska M; Kamińska H; Bień E; Połczyńska K; Stachowicz-Stencel T; Szołkiewicz A
Med Wieku Rozwoj; 2005; 9(3 Pt 2):463-9. PubMed ID: 16719158
[TBL] [Abstract][Full Text] [Related]
6. [Does the growth hormone pharmacokinetic profile help to predict the treatment response?].
Bozzola M; Radetti G; Elmlinger M; Strasburger CJ
Arch Pediatr; 1998; 5 Suppl 4():322S-326S. PubMed ID: 9853077
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with authentic recombinant human growth hormone.
Ranke MB
Acta Paediatr Scand Suppl; 1986; 325():90-2. PubMed ID: 3296642
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study.
Iughetti L; Tornese G; Street ME; Napoli F; Giavoli C; Antoniazzi F; Stagi S; Luongo C; Azzolini S; Ragusa L; Bona G; Zecchino C; Aversa T; Persani L; Guazzarotti L; Zecchi E; Pietropoli A; Zucchini S
Ital J Pediatr; 2016 Nov; 42(1):93. PubMed ID: 27809913
[TBL] [Abstract][Full Text] [Related]
9. Lack of clinical evidence of sodium retention in children with idiopathic short stature treated with recombinant growth hormone.
DiMartino-Nardi J; Wesoly S; Schwartz L; Saenger P
Metabolism; 1993 Jun; 42(6):730-4. PubMed ID: 8510517
[TBL] [Abstract][Full Text] [Related]
10. Investigating significant health trends in growth hormone treatments registry: rationale, aims and design of a nationwide prospective registry (study protocol).
Schnabel D; Kreitschmann-Andermahr I; Strasburger CJ; Pittrow D; Pausch C; Woelfle J;
Orphanet J Rare Dis; 2023 May; 18(1):112. PubMed ID: 37165422
[TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of Omnitrope
Backeljauw P; Kanumakala S; Loche S; Schwab KO; Miller BS; Levy R; McCormick K; Zouater H; Zabransky M; Campbell K
Eur J Pediatr; 2022 Jun; 181(6):2367-2378. PubMed ID: 35275291
[TBL] [Abstract][Full Text] [Related]
12. Patterns of recombinant growth hormone therapy use and growth responses among children with chronic kidney disease.
Ng DK; Carroll MK; Kaskel FJ; Furth SL; Warady BA; Greenbaum LA
Pediatr Nephrol; 2021 Dec; 36(12):3905-3913. PubMed ID: 34115207
[TBL] [Abstract][Full Text] [Related]
13. [Historical perspective on growth hormone treatment in children].
Wit JM
Tijdschr Kindergeneeskd; 1992 Oct; 60(5):135-9. PubMed ID: 1448803
[TBL] [Abstract][Full Text] [Related]
14. Clinical inquiries: can recombinant growth hormone effectively treat idiopathic short stature?
Von Fange T; McDiarmid T; Mackler L; Zolotor A
J Fam Pract; 2008 Sep; 57(9):611-2. PubMed ID: 18786336
[TBL] [Abstract][Full Text] [Related]
15. The safety and effectiveness of human growth hormone using pharmacological dosing.
Slyper A
Med Hypotheses; 1995 Dec; 45(6):523-8. PubMed ID: 8771045
[TBL] [Abstract][Full Text] [Related]
16. Effects of growth hormone administration in pediatric renal allograft recipients.
Bartosh S; Kaiser B; Rezvani I; Polinsky M; Schulman S; Palmer J; Baluarte HJ
Pediatr Nephrol; 1992 Jan; 6(1):68-73. PubMed ID: 1536744
[TBL] [Abstract][Full Text] [Related]
17. PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope
Backeljauw P; Miller BS; Levy R; McCormick K; Zouater H; Zabransky M; Campbell K
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):431-440. PubMed ID: 33647196
[TBL] [Abstract][Full Text] [Related]
18. Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.
Ranke MB
Front Endocrinol (Lausanne); 2021; 12():720419. PubMed ID: 34539573
[TBL] [Abstract][Full Text] [Related]
19. Growth, short stature, and the use of growth hormone: considerations for the practicing pediatrician--an update.
Schwartz ID; Grunt JA
Curr Probl Pediatr; 1997 Jan; 27(1):14-40. PubMed ID: 9111702
[No Abstract] [Full Text] [Related]
20. Biosynthetic human growth hormone: current status and future questions.
Thompson RG; Conforti P; Holcombe J
J Endocrinol Invest; 1989; 12(8 Suppl 3):35-9. PubMed ID: 2809097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
